These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27689212)

  • 1. Mesalazine in preventing acute diverticulitis occurrence: a meta-analysis of randomized controlled trials.
    Tursi A; Picchio M
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):409-11. PubMed ID: 27689212
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesalamine Does Not Help Prevent Recurrent Acute Colonic Diverticulitis: Meta-Analysis of Randomized, Placebo-Controlled Trials.
    Khan MA; Ali B; Lee WM; Howden CW
    Am J Gastroenterol; 2016 Apr; 111(4):579-81. PubMed ID: 27125717
    [No Abstract]   [Full Text] [Related]  

  • 3. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
    Picchio M; Elisei W; Tursi A
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):291-297. PubMed ID: 30240473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New medical strategies for the management of acute diverticulitis.
    Tursi A
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1293-304. PubMed ID: 26289102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials.
    Picchio M; Elisei W; Brandimarte G; Di Mario F; Malfertheiner P; Scarpignato C; Tursi A
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S64-9. PubMed ID: 27622370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Khan RMA; Ali B; Hajibandeh S; Hajibandeh S
    Colorectal Dis; 2018 Jun; 20(6):469-478. PubMed ID: 29520987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent versus every-day mesalazine therapy in preventing complications of diverticular disease: a long-term follow-up study.
    Tursi A; Di Mario F; Brandimarte G; Elisei W; Picchio M; Loperfido S; Dal Bo' N; Ferrara F; Marcello R; Heras Salvat H; Scarpignato C
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(23):3244-8. PubMed ID: 24338468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence.
    Tursi A; Elisei W; Giorgetti GM; Inchingolo CD; Nenna R; Picchio M; Maiorano M; Penna A; Lecca PG; Brandimarte G
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):342-8. PubMed ID: 23426537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesalamine (5-ASA) for the prevention of recurrent diverticulitis (Review).
    Carabotti M; Annibale B
    Tech Coloproctol; 2019 Jun; 23(6):597-599. PubMed ID: 31346815
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
    Barbara G; Cremon C; Barbaro MR; Bellacosa L; Stanghellini V
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S60-3. PubMed ID: 27622369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease.
    Gatta L; Di Mario F; Curlo M; Vaira D; Pilotto A; Lucarini P; Lera M; Enkleda K; Franzé A; Scarpignato C
    Intern Emerg Med; 2012 Apr; 7(2):133-7. PubMed ID: 21279478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminosalicylates.
    Gross V
    Dig Dis; 2012; 30(1):92-9. PubMed ID: 22572694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up.
    Comparato G; Fanigliulo L; Cavallaro LG; Aragona G; Cavestro GM; Iori V; Maino M; Mazzocchi G; Muzzetto P; Colla G; Sianesi M; Franzé A; Mario FD
    Dig Dis Sci; 2007 Nov; 52(11):2934-41. PubMed ID: 17410435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic management of acute uncomplicated diverticulitis.
    Fan YC; Peery AF
    Minerva Gastroenterol Dietol; 2017 Jun; 63(2):143-151. PubMed ID: 27990793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.
    Tursi A; Brandimarte G; Daffinà R
    Dig Liver Dis; 2002 Jul; 34(7):510-5. PubMed ID: 12236485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
    Rutgeerts P
    Gut; 2001 Apr; 48(4):452-3. PubMed ID: 11247886
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.
    Maconi G; Barbara G; Bosetti C; Cuomo R; Annibale B
    Dis Colon Rectum; 2011 Oct; 54(10):1326-38. PubMed ID: 21904150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial.
    Stollman N; Magowan S; Shanahan F; Quigley EM;
    J Clin Gastroenterol; 2013 Aug; 47(7):621-9. PubMed ID: 23426454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of colonic diverticular disease: are we sure the aim is right?
    Bassotti G; Villanacci V
    Intern Emerg Med; 2012 Apr; 7(2):97-8. PubMed ID: 21424908
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of 5-ASA in the treatment of colonic diverticular disease.
    Gatta L; Vakil N; Vaira D; Pilotto A; Curlo M; Comparato G; Leandro G; Ferro U; Lera M; Milletti S; Di Mario F
    J Clin Gastroenterol; 2010 Feb; 44(2):113-9. PubMed ID: 19561530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.